Import Aesculuside B — Buy in Bulk from Supplier in China

Aesculuside B is a saponin compound extracted from Aesculus wilsonii, supplied as a powder with a molecular formula of C48H78O22 and a molecular weight of 1007.12. The product meets a purity standard of over 98% as determined by HPLC-ELSD, ensuring a consistent and reliable active ingredient profile for research and industrial applications. The CAS number 26339-92-4 confirms its chemical identity in global databases, while the listed plant source ties the extract to its botanical origin.

This compound is typically used in pharmaceutical and nutraceutical formulations due to its bioactivity, with standard industry practice involving rigorous solvent extraction and purification to maintain the saponin’s structural integrity. The powder form allows for precise dosing, and typical particle size ranges for such extracts fall within 80-120 mesh, though this supplier does not specify a measured value. Aesculuside B is known for its stability under standard storage conditions, with a shelf life of 24 months when kept in a cool, dry environment below 25°C.

Primary buyers include research institutions, herbal supplement manufacturers, and pharmaceutical companies developing vascular health products. The supplier, based in Nanjing’s Jinling Biomedical Science and Technology Industrial Park, offers year-round availability and highlights its in-house R&D team as a technical advantage. Bulk packaging is standard for such extracts, often in 25 kg fiber drums with inner polyethylene bags, though the exact packaging details should be confirmed directly with the supplier for compliance with import regulations.

Nanjing Spring & Autumn Biological Engineering Co., Ltd. operates from Room 805, No. 2, Sheng Li Cun Road in Nanjing’s Xuanwu District, within the Jinling Biomedical Science and Technology Industrial Park. The company is classified as an imported-tier supplier with a harbor trust tier, indicating a baseline level of verification for international trade. Its address places it in a hub for biomedical innovation, suggesting access to specialized infrastructure for plant extract production.

The supplier’s profile notes that Aesculuside B is developed by its in-house R&D technical staff, which may indicate a focus on proprietary extraction or purification methods. However, the listed response rate of 0.00% and average response time of 0 hours suggest limited engagement with inquiries, a factor buyers should consider when evaluating reliability. No additional details about certifications, production capacity, or export history are provided in the available data.